ArticleBMC microbiology2025
The role of cervical microbiome in cervical incompetence: insights from 16 S rRNA metagenomic sequencing.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cervical incompetence (CI) is recognized as a critical factor contributing to mid-pregnancy miscarriage and preterm delivery, significantly affecting pregnancy outcomes. Despite this, the specific role of the microbiome in this pathological process remains inadequately understood. This study seeks to elucidate the core microbiome associated with CI in pregnant women and explore its potential biological mechanisms. Utilizing 16 S rRNA metagenomic sequencing, we examined the cervical mucus microbiota of women with CI both pre-operatively (PreOp) and post-operatively (PostOp). Subsequently, the immunomodulatory effects of these microbial communities on the immune system were systematically assessed using quantitative real-time PCR, Western blotting, and enzyme-linked immunosorbent assay. The findings revealed a significant reduction in microbial diversity and richness in PostOp cervical mucus, alongside notable alterations in microbiota composition. The genera Lactobacillus, Bifidobacterium, Gardnerella, Streptococcus, and Anaerococcus were identified as predominant. Further analysis demonstrated that treatment with 25% Lactobacillus crispatus (L. crispatus) supernatants, in comparison to 25% Group B Streptococcus (GBS) supernatants, resulted in high cell viability and normal morphology in HcerEpic cells. Importantly, the combination of 25% L. crispatus and 25% GBS supernatants significantly reduced the mRNA and protein expression levels of Toll-like receptor 4 (TLR4), Toll-like receptor 2 (TLR2), and nuclear factor kappa B (NF-κB) in vitro. These results indicate that L. crispatus may play a role in modulating cervical inflammation in CI by suppressing the TLR/NF-κB signaling pathway, potentially contributing to a more stable cervical microenvironment during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.